ZLAB Financials: Zai Lab Limited AI Analysis



Financials

ZLAB Financial

Zai Lab Limited

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$18.49

Open

$18.45

Day's Range

$18.21 - $18.7

52 week range

$15.96 - $41.2

Volume

1.1M

Avg.Volume

863.1K

Dividend yield

EPS (TTM)

-1.70

Market Cap

$2.0B

What is Zai Lab Limited?

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. The firm is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The firm has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	453	99	127	116	109	106
Revenue Growth (YoY)	8%	-7%	17%	14%	9%	22%
Cost of Revenue	178	38	50	46	42	38
Gross Profit	275	61	76	69	67	67
Selling, General & Admin	279	65	73	70	71	63
Research & Development	225	65	61	47	50	60
Operating Expenses	505	130	134	118	121	124
Other Non Operating Income (Expenses)	3	0	0	0	3	1
Pretax Income	-179	-49	-53	-35	-40	-48
Income Tax Expense	-1	1	-2	0	0	0
Net Income	-178	-51	-50	-35	-40	-48
Net Income Growth	-28.99%	6%	-38%	-15%	-50%	-9%
Shares Outstanding (Diluted)	1,107.39	1,107.39	1,106.17	1,102.07	1,091.93	1,080.82
Shares Change (YoY)	2%	2%	8%	12%	12%	11%
EPS (Diluted)	-0.16	-0.04	-0.04	-0.03	-0.03	-0.04
EPS Growth	-35%	3%	-43%	-23%	-55%	-19%
Free Cash Flow	-132	-34	-27	-36	-35	-65
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	60.7%	61.61%	59.84%	59.48%	61.46%	63.2%
Operating Margin	-50.77%	-69.69%	-45.66%	-41.37%	-49.54%	-52.83%
Profit Margin	-39.29%	-51.51%	-39.37%	-30.17%	-36.69%	-45.28%
Free Cash Flow Margin	-29.13%	-34.34%	-21.25%	-31.03%	-32.11%	-61.32%
EBITDA	-215	-66	-55	-45	-51	-53
EBITDA Margin	-47.46%	-66.66%	-43.3%	-38.79%	-46.78%	-50%
D&A For EBITDA	15	3	3	3	3	3
EBIT	-230	-69	-58	-48	-54	-56
EBIT Margin	-50.77%	-69.69%	-45.66%	-41.37%	-49.54%	-52.83%
Effective Tax Rate	0.55%	-2.04%	3.77%	0%	0%	0%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

453

127

116

109

106

Revenue Growth (YoY)

-7%

17%

14%

22%

Cost of Revenue

178

Gross Profit

275

Selling, General & Admin

279

Research & Development

225

Operating Expenses

505

130

134

118

121

124

Other Non Operating Income (Expenses)

Pretax Income

-179

-49

-53

-35

-40

-48

Income Tax Expense

-1

-2

Net Income

-178

-51

-50

-35

-40

-48

Net Income Growth

-28.99%

-38%

-15%

-50%

-9%

Shares Outstanding (Diluted)

1,107.39

1,106.17

1,102.07

1,091.93

1,080.82

Shares Change (YoY)

12%

11%

EPS (Diluted)

-0.16

-0.04

-0.03

-0.04

EPS Growth

-35%

-43%

-23%

-55%

-19%

Free Cash Flow

-132

-34

-27

-36

-35

-65

Free Cash Flow Per Share

Gross Margin

60.7%

61.61%

59.84%

59.48%

61.46%

63.2%

Operating Margin

-50.77%

-69.69%

-45.66%

-41.37%

-49.54%

-52.83%

Profit Margin

-39.29%

-51.51%

-39.37%

-30.17%

-36.69%

-45.28%

Free Cash Flow Margin

-29.13%

-34.34%

-21.25%

-31.03%

-32.11%

-61.32%

EBITDA

-215

-66

-55

-45

-51

-53

EBITDA Margin

-47.46%

-66.66%

-43.3%

-38.79%

-46.78%

-50%

D&A For EBITDA

EBIT

-230

-69

-58

-48

-54

-56

EBIT Margin

-50.77%

-69.69%

-45.66%

-41.37%

-49.54%

-52.83%

Effective Tax Rate

0.55%

-2.04%

3.77%

Follow-Up Questions

What are Zai Lab Limited's key financial statements?



According to the latest financial statement (Form-10K), Zai Lab Limited has a total asset of $0, Net loss of $0

What are the key financial ratios for ZLAB?



Zai Lab Limited's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Zai Lab Limited's revenue broken down by segment or geography?



Zai Lab Limited largest revenue segment is Innovative Therapies, at a revenue of 3,587,394,608 in the most earnings release.For geography, Greater China and United States is the primary market for Zai Lab Limited, at a revenue of 3,587,394,608.

Is Zai Lab Limited profitable?



no, according to the latest financial statements, Zai Lab Limited has a net loss of $0

Does Zai Lab Limited have any liabilities?



no, Zai Lab Limited has liability of 0

How many outstanding shares for Zai Lab Limited?



Zai Lab Limited has a total outstanding shares of 0

Zai Lab Limited (ZLAB) Financial

ZLAB Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Zai Lab Limited?

Zai Lab Limited (ZLAB) Financial

ZLAB Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Zai Lab Limited?

ZLAB Income

Follow-Up Questions

What are Zai Lab Limited's key financial statements?

What are the key financial ratios for ZLAB?

How is Zai Lab Limited's revenue broken down by segment or geography?

Is Zai Lab Limited profitable?

Does Zai Lab Limited have any liabilities?

How many outstanding shares for Zai Lab Limited?